Kane Biotech Correlations

KNBIF Stock  USD 0.03  0  10.77%   
The current 90-days correlation between Kane Biotech and Bioxytran is 0.14 (i.e., Average diversification). The correlation of Kane Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Kane Biotech Correlation With Market

Poor diversification

The correlation between Kane Biotech and DJI is 0.61 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Kane Biotech and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Kane Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kane Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kane Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kane Biotech to buy it.

Moving together with Kane Pink Sheet

  0.62ZDZT Zhengduozhe TechnologyPairCorr
  0.83BNEFF Bonterra Energy CorpPairCorr
  0.81TLOFF Talon Metals CorpPairCorr
  0.86CAMZF Camino MineralsPairCorr
  0.72JOE St Joe Company Earnings Call This WeekPairCorr
  0.74BLAGF Blue Lagoon ResourcesPairCorr
  0.76CYD China Yuchai Interna Earnings Call This WeekPairCorr
  0.8FRSB First Resource BankPairCorr
  0.84PYTCY Playtech PLC ADRPairCorr
  0.67DUK-PA Duke EnergyPairCorr
  0.83YLLXF Yellow Cake plcPairCorr

Moving against Kane Pink Sheet

  0.43ARGX argenx NV ADR Earnings Call Next WeekPairCorr
  0.36BAM Brookfield Asset ManPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

BZYRMYNDF
BVAXFBIXT
BUDZBVAXF
PMEDFBIXT
TXTMMYNDF
TXTMBZYR
  

High negative correlations

BVAXFTXTM
BUDZTXTM
PMEDFFAMDF
BUDZMYNDF
BUDZFAMDF
TXTMBIXT

Risk-Adjusted Indicators

There is a big difference between Kane Pink Sheet performing well and Kane Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Kane Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
BIXT  5.14 (0.34) 0.00  0.50  0.00 
 12.92 
 40.67 
MYNDF  1.86 (0.22) 0.00 (0.08) 0.00 
 0.00 
 113.60 
BZYR  9.01  0.64  0.04  0.14  11.57 
 21.05 
 134.21 
TXTM  4.15  0.38  0.07  0.37  4.84 
 8.82 
 18.85 
FAMDF  51.74  18.83  0.33 (1.29) 27.11 
 200.00 
 480.00 
BVAXF  5.19 (0.73) 0.00 (4.75) 0.00 
 9.09 
 36.58 
GLWLF  1.21  0.09  0.00  0.12  0.00 
 5.25 
 27.60 
THER  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
PMEDF  7.75  1.51  0.13  12.65  6.65 
 18.00 
 139.39 
BUDZ  9.99  0.37  0.01 (0.07) 11.30 
 33.33 
 58.33 

Be your own money manager

Our tools can tell you how much better you can do entering a position in Kane Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Cryptocurrency Center Now

   

Cryptocurrency Center

Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
All  Next Launch Module

Kane Biotech Corporate Management

Kevin ColePres IncProfile
Wendy NachtigallDirector MarketingProfile
Gregory SchultzChief BoardProfile
Lorne GorberInvestor RelationsProfile
Ray DupuisChief OfficerProfile